Selected-GenAtlas references SOURCE GeneCards NCBI Gene Swiss-Prot Ensembl
HGNC UniGene Nucleotide OMIM UCSC
Home Page
FLASH GENE
Symbol SOX11 contributors: mct - updated : 23-01-2018
HGNC name SRY (sex determining region Y)-box 11
HGNC id 11191
EXPRESSION
Type restricted
   expressed in (based on citations)
organ(s)
SystemOrgan level 1Organ level 2Organ level 3Organ level 4LevelPubmedSpeciesStageRna symbol
Digestiveliver    
 mouthtongue   
Nervousbrain     Homo sapiensAdult
Visualeye    
tissue
SystemTissueTissue level 1Tissue level 2LevelPubmedSpeciesStageRna symbol
Nervousperipherous   
cells
SystemCellPubmedSpeciesStageRna symbol
Nervousneuron
cell lineage
cell lines
fluid/secretion
at STAGE
physiological period fetal
Text high levels in developing sensory neurons system, somites, limbs, facial mesenchyme, kidney, lung
PROTEIN
PHYSICAL PROPERTIES
STRUCTURE
motifs/domains
  • an high mobility group (HMG) domain
  • a DNA binding domain responsible for selective cooperation with the POU factor POU3F2
  • a autoinhibitory domain that can repress promiscuous binding of to DNA and plays an important role in regulating the recruitment of to specific genes
  • a transactivation domain in the carboxyl terminus (transcription activation)
  • HOMOLOGY
    interspecies homolog to murine Sox11
    homolog to C.elegans Y56a3a.7
    Homologene
    FAMILY SRY-related HMG box family of transcription factors
    CATEGORY transcription factor
    SUBCELLULAR LOCALIZATION     intracellular
    intracellular,cytoplasm
    intracellular,nucleus,chromatin/chromosome
    basic FUNCTION
  • modulator of LINE retroposons promoter activity
  • playing a role in the developing nervous system
  • playing a central regulatory role during neuronal maturation and mechanistically separate cell cycle withdrawal from the establishment of neuronal properties
  • playing a central role in regulating events that promote neurite growth and neuron survival
  • expression of SOX11 and POU3F3 may be modulated by the cell-type specific machinery
  • required for neuron survive and neurite growth
  • transcription factor that is involved in tissue remodeling during embryogenesis and is crucial for neurogenesis
  • pathogenic role of SOX11 is associated with its de novo expression in some aggressive lymphoid malignancies, which is mediated by a shift from inactivating to activating histone modifications
  • SOX11 and SOX4 play critical roles in retinal development, during which they display specific and unique expression patterns
  • contributes to tumor development by altering the terminal B-cell differentiation program of mantle cell lymphoma
  • CELLULAR PROCESS nucleotide, transcription, regulation
    PHYSIOLOGICAL PROCESS development
    text neurogenesis
    PATHWAY
    metabolism
    signaling
    a component
    INTERACTION
    DNA binding
    RNA
    small molecule metal binding,
    protein
  • DBN1, SETMAR, HILPDA, are direct targets of the SOX11 protein (are direct transcriptional targets of the SOX11 protein)
  • SOX11 represents a synergistic factor for WT1 in regulating the WNT4 gene expression that is critical for nephrogenesis during kidney ontogeny
  • regulation of TANK expression is, at least in part, controlled by the injury-associated transcription factor SOX11
  • PAX5 is one of the major SOX11 direct targets
  • SOX11 is a potential regulator of GDF5 expression in joint maintenance, suggesting a possible role in the pathogenesis of osteoarthritis
  • SOX11 promotes tumor angiogenesis through transcriptional regulation of PDGFA in mantle cell lymphoma
  • GATA4 and SOX11 are functional downstream targets of CBX7 in controlling axon regeneration
  • cell & other
    REGULATION
    induced by retinoic acid for 5 weeks
    ASSOCIATED DISORDERS
    corresponding disease(s) CSSS7
    Other morbid association(s)
    TypeGene ModificationChromosome rearrangementProtein expressionProtein Function
    tumoral     --over  
    in classical medulloblastomas
    tumoral     --other  
    aberrantly expressed in mantle cell lymphoma (MCL)
    Susceptibility
    Variant & Polymorphism
    Candidate gene
    Marker
    Therapy target
    ANIMAL & CELL MODELS